| Disease | Target Count | P-value |
|---|---|---|
| non-small cell lung cancer | 2890 | 2.1e-19 |
| tuberculosis | 2010 | 2.1e-06 |
| malignant mesothelioma | 3232 | 3.9e-06 |
| ovarian cancer | 8520 | 6.5e-06 |
| ependymoma | 4679 | 2.6e-05 |
| osteosarcoma | 7950 | 6.3e-05 |
| atypical teratoid / rhabdoid tumor | 5112 | 9.3e-05 |
| Down syndrome | 499 | 2.7e-04 |
| lung adenocarcinoma | 2716 | 2.8e-04 |
| medulloblastoma, large-cell | 6241 | 1.3e-03 |
| subependymal giant cell astrocytoma | 2287 | 2.5e-03 |
| group 4 medulloblastoma | 1855 | 6.0e-03 |
| primary Sjogren syndrome | 735 | 7.7e-03 |
| spina bifida | 1074 | 4.7e-02 |
| Disease | log2 FC | p |
|---|---|---|
| atypical teratoid / rhabdoid tumor | -1.300 | 9.3e-05 |
| Down syndrome | 1.800 | 2.7e-04 |
| ependymoma | -1.100 | 2.6e-05 |
| group 4 medulloblastoma | -1.300 | 6.0e-03 |
| lung adenocarcinoma | 1.222 | 2.8e-04 |
| malignant mesothelioma | 1.400 | 3.9e-06 |
| medulloblastoma, large-cell | -1.600 | 1.3e-03 |
| non-small cell lung cancer | -1.038 | 2.1e-19 |
| osteosarcoma | -1.274 | 6.3e-05 |
| ovarian cancer | -1.900 | 6.5e-06 |
| primary Sjogren syndrome | 1.100 | 7.7e-03 |
| spina bifida | -1.083 | 4.7e-02 |
| subependymal giant cell astrocytoma | -2.566 | 2.5e-03 |
| tuberculosis | -1.100 | 2.1e-06 |
